What is he best known for?
The fields of study he is best known for:
- Gene
- Enzyme
- Internal medicine
Hanry Yu mainly investigates Cell biology, Biomedical engineering, In vivo, Hepatocyte and Biochemistry.
His work on Cell biology is being expanded to include thematically relevant topics such as Ubiquitin.
His studies in Biomedical engineering integrate themes in fields like Microfluidics, Sciatic nerve, Nerve guidance conduit, Nerve growth factor and Perfusion.
His work deals with themes such as Absorption, Photochemistry, Fluorescence and Molecular probe, which intersect with In vivo.
His Hepatocyte research is multidisciplinary, incorporating elements of Drug, Biophysics, Matrix and Bioreactor.
His Biochemistry study combines topics from a wide range of disciplines, such as Kinesin and Microtubule.
His most cited work include:
- FLUORESCENCE CORRELATION SPECTROSCOPY (768 citations)
- A practical guide to microfluidic perfusion culture of adherent mammalian cells (359 citations)
- A novel 3D mammalian cell perfusion-culture system in microfluidic channels (355 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Cell biology, Hepatocyte, Biomedical engineering, In vitro and Biophysics.
Hanry Yu has researched Cell biology in several fields, including Embryonic stem cell and Cellular differentiation.
His Cellular differentiation research is multidisciplinary, relying on both Stem cell and Induced pluripotent stem cell.
Hepatocyte is a subfield of Biochemistry that Hanry Yu studies.
Hanry Yu works in the field of Biomedical engineering, focusing on Tissue engineering in particular.
His study connects In vivo and In vitro.
He most often published in these fields:
- Cell biology (30.51%)
- Hepatocyte (16.92%)
- Biomedical engineering (12.99%)
What were the highlights of his more recent work (between 2015-2021)?
- Cell biology (30.51%)
- Hepatocyte (16.92%)
- In vitro (11.48%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Cell biology, Hepatocyte, In vitro, Induced pluripotent stem cell and Extracellular matrix.
His Ubiquitin research extends to the thematically linked field of Cell biology.
His research in In vitro intersects with topics in Cell, Biophysics, In vivo and Amyloidosis.
His study in In vivo is interdisciplinary in nature, drawing from both Pharmacology and Drug.
Hanry Yu combines subjects such as Cancer research, Liver cell, Cellular differentiation and Tyrosine-kinase inhibitor with his study of Induced pluripotent stem cell.
The study incorporates disciplines such as Lumen and Cell polarity in addition to Extracellular matrix.
Between 2015 and 2021, his most popular works were:
- Heralding a new paradigm in 3D tumor modeling. (69 citations)
- PTEN-L is a novel protein phosphatase for ubiquitin dephosphorylation to inhibit PINK1–Parkin-mediated mitophagy (56 citations)
- PTEN-L is a novel protein phosphatase for ubiquitin dephosphorylation to inhibit PINK1–Parkin-mediated mitophagy (56 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Internal medicine
Hanry Yu mainly investigates Cell biology, Cancer research, Induced pluripotent stem cell, Hepatocyte and Extracellular matrix.
His Cell biology research incorporates themes from Ubiquitin and Adherens junction.
He has included themes like Liver cell and Cellular differentiation in his Induced pluripotent stem cell study.
His research investigates the connection between Cellular differentiation and topics such as Stem cell that intersect with problems in Scaffold, Tissue engineering, Hepatocyte differentiation and Nanotechnology.
His Hepatocyte research is multidisciplinary, relying on both Spheroid, Viability assay, Regeneration, Alanine transaminase and Mitochondrion.
His studies deal with areas such as Integrin, Cell adhesion, Lumen and Cell polarity as well as Extracellular matrix.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
